Published in ScientificWorldJournal on October 27, 2013
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24
The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58
The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry (2004) 5.70
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med (2004) 1.64
Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders. J Affect Disord (1984) 1.24
Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients. J Affect Disord (2002) 1.14
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry (2010) 1.07
Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affect Disord (2006) 1.04
Anxious and nonanxious depression. Am J Psychiatry (1993) 1.01
Severe and anxious depression: combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol (2011) 0.96
Anxious depression: clinical features and treatment. Curr Psychiatry Rep (2009) 0.95
Anxious and non-anxious forms of major depression: familial, personality and symptom characteristics. Psychol Med (2013) 0.83
Adjunctive pregabalin to quetiapine in acute mania. Clin Neuropharmacol (2009) 1.40
Apathy, cognitive deficits and functional impairment in schizophrenia. Schizophr Res (2011) 0.96
Delusionality of body image beliefs in eating disorders. Psychiatry Res (2012) 0.92
Restless legs syndrome associated with the combined use of quetiapine and venlafaxine. J Clin Psychopharmacol (2014) 0.88
Gonadal axis hormones in psychiatric male patients after a suicide attempt. Eur Arch Psychiatry Clin Neurosci (2006) 0.87
Reversal of increased arterial stiffness in severely depressed women after 6-week antidepressant treatment. J Affect Disord (2009) 0.86
A magnetic resonance imaging study of hippocampal, amygdala and subgenual prefrontal cortex volumes in major depression subtypes: melancholic versus psychotic depression. J Affect Disord (2012) 0.85
Pregabalin in the discontinuation of long-term benzodiazepines' use. Hum Psychopharmacol (2008) 0.85
Biogenic amine turnover and serum cholesterol in suicide attempt. Eur Arch Psychiatry Clin Neurosci (2002) 0.84
The safety of the electroconvulsive therapy-aripiprazole combination: four case reports. J ECT (2008) 0.83
Plasma total cholesterol in psychiatric patients after a suicide attempt and in follow-up. J Affect Disord (2012) 0.82
Adjunctive low-dose amisulpride in motor conversion disorder. Clin Neuropharmacol (2009) 0.81
Pregabalin in zolpidem dependence and withdrawal. Clin Neuropharmacol (2011) 0.81
Olanzapine-induced "restless arms syndrome". J Clin Psychopharmacol (2009) 0.81
Development of tardive dyskinesia in a patient taking amisulpride. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.81
Remission of migraine attacks in a patient with depression who is taking pregabalin. Clin Neuropharmacol (2008) 0.80
Dimensional approach to delusions in psychotic depression in the elderly: factor structure and clinical correlates. Int J Geriatr Psychiatry (2009) 0.79
Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series. Int Clin Psychopharmacol (2008) 0.79
Lamotrigine-associated exacerbation of positive symptoms in paranoid schizophrenia. Schizophr Res (2007) 0.79
Testosterone and dehydroepiandrosterone sulfate in female anxious and non-anxious major depression. Int J Psychiatry Clin Pract (2013) 0.79
Is insight in schizophrenia multidimensional? Internal structure and associations of the Greek version of the Schedule for the Assessment of Insight-Expanded. Psychiatry Res (2013) 0.78
Aggression, impulsivity, plasma sex hormones, and biogenic amine turnover in a forensic population of rapists. J Sex Marital Ther (2003) 0.78
Self-rated and performance-based empathy in schizophrenia: the impact of cognitive deficits. Soc Neurosci (2014) 0.78
Caffeine challenge and breath-holding duration in patients with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.78
Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatr Dis Treat (2013) 0.77
Clinical correlates of age of onset in psychotic depression. Arch Gerontol Geriatr (2010) 0.77
Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia. Psychiatry Res (2002) 0.77
Sex hormones and biogenic amine turnover of sex offenders in relation to their temperament and character dimensions. Psychiatry Res (2004) 0.77
The safety of the electroconvulsive therapy-escitalopram combination. J ECT (2008) 0.77
Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome. World J Biol Psychiatry (2008) 0.77
Bupropion-induced sleepwalking. J Clin Psychopharmacol (2010) 0.77
Lamotrigine administration in panic disorder with agoraphobia. Clin Neuropharmacol (2010) 0.76
Manic symptoms associated with quetiapine treatment. Eur Neuropsychopharmacol (2003) 0.76
Bilateral ankle oedema in a patient taking escitalopram. World J Biol Psychiatry (2009) 0.76
Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants. Depress Res Treat (2013) 0.76
Platelet monoamine oxidase activity and psychometric correlates in male violent offenders imprisoned for homicide or other violent acts. Eur Arch Psychiatry Clin Neurosci (2004) 0.76
Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration. Clin Neuropharmacol (2008) 0.76
Pregabalin augmentation to sertraline-risperidone combination in the treatment of obsessive-compulsive disorder. Prim Care Companion J Clin Psychiatry (2008) 0.75
Low-dose aripiprazole in the treatment of SSRI-induced bruxism. J Neuropsychiatry Clin Neurosci (2012) 0.75
Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report. Ann Gen Psychiatry (2007) 0.75
Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease. J Neuropsychiatry Clin Neurosci (2010) 0.75
Psychotic major depression in older people: a systematic review. Int J Geriatr Psychiatry (2014) 0.75
A case of severe toluene withdrawal syndrome treated with clonazepam. J Neuropsychiatry Clin Neurosci (2010) 0.75
Duloxetine-induced cutaneous adverse reaction. J Clin Psychopharmacol (2008) 0.75
Pregabalin in the treatment of benzodiazepine-induced obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.75
Mirtazapine-associated urinary retention. J Neuropsychiatry Clin Neurosci (2010) 0.75
Fluvoxamine in the treatment of corticosteroid-induced obsessive-compulsive disorder. Clin Neuropharmacol (2009) 0.75
Safety of the electroconvulsive therapy-ziprasidone combination. J ECT (2010) 0.75
Acute pregabalin reversal of citalopram-induced sexual dysfunction in generalized anxiety disorder. J Clin Psychopharmacol (2008) 0.75
Horse madness (hippomania) and hippophobia. Hist Psychiatry (2005) 0.75
Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia. Psychiatry Clin Neurosci (2012) 0.75
Psychotic (delusional) major depression in the elderly and suicidal behaviour. J Affect Disord (2002) 0.75
Effects of intrathecal baclofen therapy on CSF neurotransmitter metabolite levels. J Clin Psychopharmacol (2014) 0.75
Corrected QT interval changes during electroconvulsive therapy-antidepressants-atypical antipsychotics coadministration: safety issues. J ECT (2011) 0.75
Capgras delusion in paranoid schizophrenia complicated by vascular dementia. J Neuropsychiatry Clin Neurosci (2012) 0.75
Putative neuroleptic malignant syndrome associated with sertraline withdrawal. J Clin Psychopharmacol (2009) 0.75
Quetiapine-induced dose-dependent hypersalivation in mania. Clin Neuropharmacol (2009) 0.75
Episodic Visual Learning/Memory and Attentional Flexibility in Patients With Major Depressive Disorder After Clinically Effective Electroconvulsive Therapy. J ECT (2015) 0.75
Orexin-a system neuromodulation by intrathecal baclofen. J Clin Psychopharmacol (2014) 0.75
Mental disorders as mechanistic property clusters. Psychol Med (2011) 0.75
Auditory hallucinations during a caffeine challenge in a patient with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.75
Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder. World J Biol Psychiatry (2009) 0.75
Cardiac safety of the electroconvulsive therapy-paliperidone combination: a preliminary study. Gen Hosp Psychiatry (2010) 0.75
For publication: Tiagabine in the discontinuation of long-term benzodiazepine use. Psychiatry Clin Neurosci (2009) 0.75
Delusional beliefs in psychotic depression vary according to age of onset. Int J Geriatr Psychiatry (2008) 0.75
Visual and coenesthetic hallucinations associated with modafinil. J Clin Psychopharmacol (2008) 0.75